Top

Published in:

01-02-2008 | Review

Immune system irregularities in lysosomal storage disorders

Authors: Julian A. Castaneda, Ming J. Lim, Jonathan D. Cooper, David A. Pearce

Published in: Acta Neuropathologica | Issue 2/2008

Abstract

Lysosomal storage disorders (LSDs) are genetically inherited diseases characterized by the accumulation of disease-specific biological materials such as proteolipids or metabolic intermediates within the lysosome. The lysosomal compartment’s central importance to normal cellular function can be appreciated by examining the various pathologies that arise in LSDs. These disorders are invariably fatal, and many display profound neurological impairment that begins in childhood. However, recent studies have revealed that several LSDs also have irregularities in the function of the immune system. Gaucher disease, mucopolysaccharidosis VII, and α-mannosidosis are examples of a subset of LSD patients that are predisposed towards immune suppression. In contrast, GM2 gangliosidosis, globoid cell leukodystrophy, Niemann-Pick disease type C1 and juvenile neuronal ceroid lipofuscinosis are LSDs that are predisposed towards immune system hyperactivity. Antigen presentation and processing by dedicated antigen presenting cells (APCs), secretion of pore-forming perforins by cytotoxic-T lymphocytes, and release of pro-inflammatory mediators by mast cells are among the many crucial immune system functions in which the lysosome plays a central role. Although the relationship between the modification of the lysosomal compartment in LSDs and modulation of the immune system remains unknown, there is emerging evidence for early neuroimmune responses in a variety of LSDs. In this review we bridge biochemical studies on the lysosomal compartment’s role in the immune system with clinical data on immune system irregularities in a subset of LSDs.

Allen MJ, Myer BJ, Khokher AM, Rushton N, Cox TM (1997) Pro-inflammatory cytokines and the pathogenesis of Gaucher’s disease: increased release of interleukin-6 and interleukin-10. QJM 90:19–25PubMed

Andrejewski N, Punnonen EL, Guhde G, Tanaka Y, Lullmann-Rauch R, Hartmann D, von Figura K, Saftig P (1999) Normal lysosomal morphology and function in LAMP-1-deficient mice. J Biol Chem 274:12692–12701PubMed

Arda IS, Gencoglu A, Coskun M, Ozbek N, Demirhan B, Hicsonmez A (2005) A very unusual presentation of Niemann-Pick disease type B in an infant: similar findings to congenital lobar emphysema. Eur J Pediatr Surg 15:283–286PubMed

Aula P, Rapola J, Andersson LC (1975) Distribution of cytoplasmic vacuoles in blood T and B lymphocytes in two lysosomal disorders. Virchows Arch B Cell Pathol 18:263–271PubMed

Bach G, Chen CS, Pagano RE (1999) Elevated lysosomal pH in Mucolipidosis type IV cells. Clin Chim Acta 280:173–179PubMed

Balreira A, Lacerda L, Miranda CS, Arosa FA (2005) Evidence for a link between sphingolipid metabolism and expression of CD1d and MHC-class II: monocytes from Gaucher disease patients as a model. Br J Haematol 129:667–676PubMed

Barak V, Acker M, Nisman B, Kalickman I, Abrahamov A, Zimran A, Yatziv S (1999) Cytokines in Gaucher’s disease. Eur Cytokine Netw 10:205–210PubMed

Barranger JA, O’Rourke E (2001) Lessons learned from the development of enzyme therapy for Gaucher disease. J Inherit Metab Dis 24(Suppl 2):89–96. discussion 87–88PubMed

Bembi B, Comelli M, Scaggiante B, Pineschi A, Rapelli S, Gornati R, Montorfano G, Berra B, Agosti E, Romeo D (1992) Treatment of sphingomyelinase deficiency by repeated implantations of amniotic epithelial cells. Am J Med Genet 44:527–533PubMed

10.

Berger J, Moser HW, Forss-Petter S (2001) Leukodystrophies: recent developments in genetics, molecular biology, pathogenesis and treatment. Curr Opin Neurol 14:305–312PubMed

11.

Beutler E, Kuhl W (1970) The diagnosis of the adult type of Gaucher’s disease and its carrier state by demonstration of deficiency of beta-glucosidase activity in peripheral blood leukocytes. J Lab Clin Med 76:747–755PubMed

12.

Blott EJ, Griffiths GM (2002) Secretory lysosomes. Nat Rev Mol Cell Biol 3:122–131PubMed

13.

Boot RG, Verhoek M, de Fost M, Hollak CE, Maas M, Bleijlevens B, van Breemen MJ, van Meurs M, Boven LA, Laman JD, Moran MT, Cox TM, Aerts JM (2004) Marked elevation of the chemokine CCL18/PARC in Gaucher disease: a novel surrogate marker for assessing therapeutic intervention. Blood 103:33–39PubMed

14.

Bossi G, Griffiths GM (1999) Degranulation plays an essential part in regulating cell surface expression of Fas ligand in T cells and natural killer cells. Nat Med 5:90–96PubMed

15.

Brigl M, Brenner MB (2004) CD1: antigen presentation and T cell function. Annu Rev Immunol 22:817–890PubMed

16.

Bruck W, Goebel HH, Dienes P (1991) B and T lymphocytes are affected in lysosomal disorders—an immunoelectron microscopic study. Neuropathol Appl Neurobiol 17:219–222PubMed

17.

Burkhardt JK, Hester S, Lapham CK, Argon Y (1990) The lytic granules of natural killer cells are dual-function organelles combining secretory and pre-lysosomal compartments. J Cell Biol 111:2327–2340PubMed

18.

Burstein Y, Rechavi G, Rausen AR, Frisch B, Spirer Z (1985) Association of Gaucher’s disease and lymphoid malignancy in 2 children. Scand J Haematol 35:445–447PubMedCrossRef

19.

Burstein Y, Zakuth V, Rechavi G, Spirer Z (1987) Abnormalities of cellular immunity and natural killer cells in Gaucher’s disease. J Clin Lab Immunol 23:149–151PubMed

20.

Chapman HA (1998) Endosomal proteolysis and MHC class II function. Curr Opin Immunol 10:93–102PubMed

21.

Chattopadhyay S, Ito M, Cooper JD, Brooks AI, Curran TM, Powers JM, Pearce DA (2002) An autoantibody inhibitory to glutamic acid decarboxylase in the neurodegenerative disorder Batten disease. Hum Mol Genet 11:1421–1431PubMed

22.

Chen YQ, Rafi MA, de Gala G, Wenger DA (1993) Cloning and expression of cDNA encoding human galactocerebrosidase, the enzyme deficient in globoid cell leukodystrophy. Hum Mol Genet 2:1841–1845PubMed

23.

Cooper JD (2003) Progress towards understanding the neurobiology of Batten disease or neuronal ceroid lipofuscinosis. Curr Opin Neurol 16:121–128PubMed

24.

Cox TM (2001) Gaucher disease: understanding the molecular pathogenesis of sphingolipidoses. J Inherit Metab Dis 24(Suppl 2):106–121. discussion 187–108PubMed

25.

Cruz JC, Sugii S, Yu C, Chang TY (2000) Role of Niemann-Pick type C1 protein in intracellular trafficking of low density lipoprotein-derived cholesterol. J Biol Chem 275:4013–4021PubMed

26.

Daly TM, Lorenz RG, Sands MS (2000) Abnormal immune function in vivo in a murine model of lysosomal storage disease. Pediatr Res 47:757–762PubMed

27.

Davis MM, Boniface JJ, Reich Z, Lyons D, Hampl J, Arden B, Chien Y (1998) Ligand recognition by alpha beta T cell receptors. Annu Rev Immunol 16:523–544PubMed

28.

Deganuto M, Pittis MG, Pines A, Dominissini S, Kelley MR, Garcia R, Quadrifoglio F, Bembi B, Tell G (2007) Altered intracellular redox status in Gaucher disease fibroblasts and impairment of adaptive response against oxidative stress. J Cell Physiol 212:223–235PubMed

29.

Desnick RJ, Sharp HL, Grabowski GA, Brunning RD, Quie PG, Sung JH, Gorlin RJ, Ikonne JU (1976) Mannosidosis: clinical, morphologic, immunologic, and biochemical studies. Pediatr Res 10:985–996PubMed

30.

Dolman CL, McLeod PM, Chang EC (1980) Lymphocytes and urine in ceroid lipofuscinosis. Arch Pathol Lab Med 104:487–490PubMed

31.

Drozina G, Kohoutek J, Jabrane-Ferrat N, Peterlin BM (2005) Expression of MHC II genes. Curr Top Microbiol Immunol 290:147–170PubMed

32.

Ezaki J, Kominami E (2004) The intracellular location and function of proteins of neuronal ceroid lipofuscinoses. Brain Pathol 14:77–85PubMedCrossRef

33.

Finkelstein R, Nachum Z, Reissman P, Reiss ND, Besser M, Trajber I, Melamed Y (1992) Anaerobic osteomyelitis in patients with Gaucher’s disease. Clin Infect Dis 15:771–773PubMed

34.

Florena AM, Franco V, Campesi G (1996) Immunophenotypical comparison of Gaucher’s and pseudo-Gaucher cells. Pathol Int 46:155–160PubMed

35.

Formichi P, Radi E, Battisti C, Pasqui A, Pompella G, Lazzerini PE, Laghi-Pasini F, Leonini A, Di Stefano A, Federico A (2007) Psychosine-induced apoptosis and cytokine activation in immune peripheral cells of Krabbe patients. J Cell Physiol 212:737–743PubMed

36.

Gadola SD, Silk JD, Jeans A, Illarionov PA, Salio M, Besra GS, Dwek R, Butters TD, Platt FM, Cerundolo V (2006) Impaired selection of invariant natural killer T cells in diverse mouse models of glycosphingolipid lysosomal storage diseases. J Exp Med 203:2293–2303PubMed

37.

Germain RN (1994) MHC-dependent antigen processing and peptide presentation: providing ligands for T lymphocyte activation. Cell 76:287–299PubMed

38.

Geuze H (1994) EJCB-lecture. A novel lysosomal compartment engaged in antigen presentation. Eur J Cell Biol 64:3–6PubMed

39.

Glickman JN, Morton PA, Slot JW, Kornfeld S, Geuze HJ (1996) The biogenesis of the MHC class II compartment in human I-cell disease B lymphoblasts. J Cell Biol 132:769–785PubMed

40.

Godfrey DI, McConville MJ, Pellicci DG (2006) Chewing the fat on natural killer T cell development. J Exp Med 203:2229–2232PubMed

41.

Goebel HH (1995) The neuronal ceroid-lipofuscinoses. J Child Neurol 10:424–437PubMedCrossRef

42.

Goebel HH, Wisniewski KE (2004) Current state of clinical and morphological features in human NCL. Brain Pathol 14:61–69PubMedCrossRef

43.

Griffiths GM, Argon YA (1995) Structure and biogenesis of lytic granules. Curr Top Microbiol Immunol 198:39–59PubMed

44.

Holt OJ, Gallo F, Griffiths GM (2006) Regulating secretory lysosomes. J Biochem (Tokyo) 140:7–12

45.

Hsing LC, Rudensky AY (2005) The lysosomal cysteine proteases in MHC class II antigen presentation. Immunol Rev 207:229–241PubMed

46.

Huang JQ, Trasler JM, Igdoura S, Michaud J, Hanal N, Gravel RA (1997) Apoptotic cell death in mouse models of GM2 gangliosidosis and observations on human Tay-Sachs and Sandhoff diseases. Hum Mol Genet 6:1879–1885PubMed

47.

Hunziker W, Geuze HJ (1996) Intracellular trafficking of lysosomal membrane proteins. Bioessays 18:379–389PubMed

48.

Ikeda K, Goebel HH, Burck U, Kohlschutter A (1982) Ultrastructural pathology of human lymphocytes in lysosomal disorders: a contribution to their morphological diagnosis. Eur J Pediatr 138:179–185PubMed

49.

Ioannou YA (2000) The structure and function of the Niemann-Pick C1 protein. Mol Genet Metab 71:175–181PubMed

50.

Jensen PE (1993) Acidification and disulfide reduction can be sufficient to allow intact proteins to bind class II MHC. J Immunol 150:3347–3356PubMed

51.

Jeyakumar M, Thomas R, Elliot-Smith E, Smith DA, van der Spoel AC, d’Azzo A, Perry VH, Butters TD, Dwek RA, Platt FM (2003) Central nervous system inflammation is a hallmark of pathogenesis in mouse models of GM1 and GM2 gangliosidosis. Brain 126:974–987PubMed

52.

Jeyakumar M, Smith DA, Williams IM, Borja MC, Neville DC, Butters TD, Dwek RA, Platt FM (2004) NSAIDs increase survival in the Sandhoff disease mouse: synergy with N-butyldeoxynojirimycin. Ann Neurol 56:642–649PubMed

53.

Kaloterakis A, Filiotou A, Koskinas J, Raptis I, Zouboulis C, Michelakakis H, Hadziyannis S (1999) Systemic AL amyloidosis in Gaucher disease. A case report and review of the literature. J Intern Med 246:587–590PubMed

54.

Kataoka T, Takaku K, Magae J, Shinohara N, Takayama H, Kondo S, Nagai K (1994) Acidification is essential for maintaining the structure and function of lytic granules of CTL. Effect of concanamycin A, an inhibitor of vacuolar type H(+)-ATPase, on CTL-mediated cytotoxicity. J Immunol 153:3938–3947PubMed

55.

Kieseier BC, Goebel HH (1994) Characterization of T-cell subclasses and NK-cells in lysosomal disorders by immuno-electron microscopy. Neuropathol Appl Neurobiol 20:604–608PubMed

56.

Kieseier BC, Goebel HH (1995) Immunelectronmicroscopic characterization of T4 and T8 lymphocytes and natural killer cells in neuronal ceroid-lipofuscinosis. Am J Med Genet 57:222–224PubMed

57.

Kieseier BC, Wisniewski KE, Goebel HH (1997) The monocyte–macrophage system is affected in lysosomal storage diseases: an immunoelectron microscopic study. Acta Neuropathol (Berl) 94:359–362

58.

Kieseier BC, Wisniewski KE, Park E, Schuller-Levis G, Mehta PD, Goebel HH (1997) Leukocytes in neuronal ceroid-lipofuscinoses: function and apoptosis. Brain Dev 19:317–322PubMed

59.

Kim Y, Ramirez-Montealegre D, Pearce DA (2003) A role in vacuolar arginine transport for yeast Btn1p and for human CLN3, the protein defective in Batten disease. Proc Natl Acad Sci USA 100:15458–15462PubMed

60.

Kimura S, Goebel HH (1988) Light and electron microscopic study of juvenile neuronal ceroid-lipofuscinosis lymphocytes. Pediatr Neurol 4:148–152PubMed

61.

Kinjo Y, Wu D, Kim G, Xing GW, Poles MA, Ho DD, Tsuji M, Kawahara K, Wong CH, Kronenberg M (2005) Recognition of bacterial glycosphingolipids by natural killer T cells. Nature 434:520–525PubMed

62.

Klein D, Bussow H, Fewou SN, Gieselmann V (2005) Exocytosis of storage material in a lysosomal disorder. Biochem Biophys Res Commun 327:663–667PubMed

63.

Kolch W (2005) Coordinating ERK/MAPK signalling through scaffolds and inhibitors. Nat Rev Mol Cell Biol 6:827–837PubMed

64.

Kornfeld S, Mellman I (1989) The biogenesis of lysosomes. Annu Rev Cell Biol 5:483–525PubMed

65.

LeVine SM, Brown DC (1997) IL-6 and TNF-alpha expression in brains of twitcher, quaking and normal mice. J Neuroimmunol 73:47–56PubMed

66.

Li P, Gregg JL, Wang N, Zhou D, O’Donnell P, Blum JS, Crotzer VL (2005) Compartmentalization of class II antigen presentation: contribution of cytoplasmic and endosomal processing. Immunol Rev 207:206–217PubMed

67.

Lichtenstein M, Zimran A, Horowitz M (1997) Cytokine mRNA in Gaucher disease. Blood Cells Mol Dis 23:395–401PubMed

68.

Liel Y, Rudich A, Nagauker-Shriker O, Yermiyahu T, Levy R (1994) Monocyte dysfunction in patients with Gaucher disease: evidence for interference of glucocerebroside with superoxide generation. Blood 83:2646–2653PubMed

69.

Lim MJ, Beake J, Bible E, Curran TM, Ramirez-Montealegre D, Pearce DA, Cooper JD (2006) Distinct patterns of serum immunoreactivity as evidence for multiple brain-directed autoantibodies in juvenile neuronal ceroid lipofuscinosis. Neuropathol Appl Neurobiol 32:469–482PubMed

70.

Lim MJ, Alexander N, Benedict JW, Chattopadhyay S, Shemilt SJ, Guerin CJ, Cooper JD, Pearce DA (2007) IgG entry and deposition are components of the neuroimmune response in Batten disease. Neurobiol Dis 25:239–251PubMed

71.

Lloyd JB, Mason RW (eds) (1996) Biology of the lysosome, subcellular biochemistry. Plenum Press, New York

72.

Lorenz RG, Tyler AN, Allen PM (1988) T cell recognition of bovine ribonuclease. Self/non-self discrimination at the level of binding to the I-Ak molecule. J Immunol 141:4124–4128PubMed

73.

Malm D, Halvorsen DS, Tranebjaerg L, Sjursen H (2000) Immunodeficiency in alpha-mannosidosis: a matched case-control study on immunoglobulins, complement factors, receptor density, phagocytosis and intracellular killing in leucocytes. Eur J Pediatr 159:699–703PubMed

74.

Marie JP, Tulliez M, Tricottet-Paczinski V, Reynes M, Diebold J (1982) Gaucher’s disease with monoclonal gammopathy. Significance of splenic plasmacytosis. Scand J Haematol 28:54–58PubMedCrossRef

75.

Markesbery WR, Robinson RO, Falace PV, Frye MD (1980) Mucopolysaccharidoses: ultrastructure of leukocyte inclusions. Ann Neurol 8:332–336PubMed

76.

Marodi L, Kaposzta R, Toth J, Laszlo A (1995) Impaired microbicidal capacity of mononuclear phagocytes from patients with type I Gaucher disease: partial correction by enzyme replacement therapy. Blood 86:4645–4649PubMed

77.

Marti GE, Ryan ET, Papadopoulos NM, Filling-Katz M, Barton N, Fleischer TA, Rick M, Gralnick HR (1988) Polyclonal B-cell lymphocytosis and hypergammaglobulinemia in patients with Gaucher disease. Am J Hematol 29:189–194PubMed

78.

McGovern MM, Aron A, Brodie SE, Desnick RJ, Wasserstein MP (2006) Natural history of type A Niemann-Pick disease: possible endpoints for therapeutic trials. Neurology 66:228–232PubMed

79.

Meikle PJ, Hopwood JJ, Clague AE, Carey WF (1999) Prevalence of lysosomal storage disorders. JAMA 281:249–254PubMed

80.

Michelakakis H, Spanou C, Kondyli A, Dimitriou E, Van Weely S, Hollak CE, Van Oers MH, Aerts JM (1996) Plasma tumor necrosis factor-a (TNF-a) levels in Gaucher disease. Biochim Biophys Acta 1317:219–222PubMed

81.

Mizukami H, Mi Y, Wada R, Kono M, Yamashita T, Liu Y, Werth N, Sandhoff R, Sandhoff K, Proia RL (2002) Systemic inflammation in glucocerebrosidase-deficient mice with minimal glucosylceramide storage. J Clin Invest 109:1215–1221PubMed

82.

Moller HJ, de Fost M, Aerts H, Hollak C, Moestrup SK (2004) Plasma level of the macrophage-derived soluble CD163 is increased and positively correlates with severity in Gaucher’s disease. Eur J Haematol 72:135–139PubMed

83.

Mor A, Philips MR (2006) Compartmentalized Ras/MAPK signaling. Annu Rev Immunol 24:771–800PubMed

84.

Morisot C, Millat G, Coeslier A, Bourgois B, Fontenoy E, Dobbelaere D, Verot L, Haouari N, Vaillant C, Gottrand F, Bogaert E, Thelliez P, Klosowski S, Djebara A, Bachiri A, Manouvrier S, Vanier MT (2005) Fetal neonatal respiratory distress in Niemann-Pick C2 and prenatal diagnosis with mutations in gene HE1/NPC2. Arch Pediatr 12:434–437PubMed

85.

Muenzer J (2004) The mucopolysaccharidoses: a heterogeneous group of disorders with variable pediatric presentations. J Pediatr 144:S27–S34PubMed

86.

Myerowitz R, Lawson D, Mizukami H, Mi Y, Tifft CJ, Proia RL (2002) Molecular pathophysiology in Tay-Sachs and Sandhoff diseases as revealed by gene expression profiling. Hum Mol Genet 11:1343–1350PubMed

87.

Neufeld EF (1991) Lysosomal storage diseases. Annu Rev Biochem 60:257–280PubMed

88.

Norflus F, Tifft CJ, McDonald MP, Goldstein G, Crawley JN, Hoffmann A, Sandhoff K, Suzuki K, Proia RL (1998) Bone marrow transplantation prolongs life span and ameliorates neurologic manifestations in Sandhoff disease mice. J Clin Invest 101:1881–1888PubMedCrossRef

89.

Ohmi K, Greenberg DS, Rajavel KS, Ryazantsev S, Li HH, Neufeld EF (2003) Activated microglia in cortex of mouse models of mucopolysaccharidoses I and IIIB. Proc Natl Acad Sci USA 100:1902–1907PubMed

90.

Padilla-Lopez S, Pearce DA (2006) Saccharomyces cerevisiae lacking Btn1p modulate vacuolar ATPase activity to regulate pH imbalance in the vacuole. J Biol Chem 281:10273–10280PubMed

91.

Page LJ, Darmon AJ, Uellner R, Griffiths GM (1998) L is for lytic granules: lsosomes that kill. Biochim Biophys Acta 1401:146–156PubMed

92.

Palmer DN, Oswald MJ, Westlake VJ, Kay GW (2002) The origin of fluorescence in the neuronal ceroid lipofuscinoses (Batten disease) and neuron cultures from affected sheep for studies of neurodegeneration. Arch Gerontol Geriatr 34:343–357PubMed

93.

Pedchenko TV, LeVine SM (1999) IL-6 deficiency causes enhanced pathology in Twitcher (globoid cell leukodystrophy) mice. Exp Neurol 158:459–468PubMed

94.

Pedchenko TV, Bronshteyn IG, LeVine SM (2000) TNF-receptor 1 deficiency fails to alter the clinical and pathological course in mice with globoid cell leukodystrophy (twitcher mice) but affords protection following LPS challenge. J Neuroimmunol 110:186–194PubMed

95.

Perry VH (2004) The influence of systemic inflammation on inflammation in the brain: implications for chronic neurodegenerative disease. Brain Behav Immun 18:407–413PubMed

96.

Peters PJ, Borst J, Oorschot V, Fukuda M, Krahenbuhl O, Tschopp J, Slot JW, Geuze HJ (1991) Cytotoxic T lymphocyte granules are secretory lysosomes, containing both perforin and granzymes. J Exp Med 173:1099–1109PubMed

97.

Pin I, Pradines S, Pincemaille O, Frappat P, Brambilla E, Vanier MT, Bost M (1990) A fatal respiratory form of type C Niemann-Pick disease. Arch Fr Pediatr 47:373–375PubMed

98.

Pinto R, Caseiro C, Lemos M, Lopes L, Fontes A, Ribeiro H, Pinto E, Silva E, Rocha S, Marcao A, Ribeiro I, Lacerda L, Ribeiro G, Amaral O, Sa Miranda MC (2004) Prevalence of lysosomal storage diseases in Portugal. Eur J Hum Genet 12:87–92PubMed

99.

Pontikis CC, Cella CV, Parihar N, Lim MJ, Chakrabarti S, Mitchison HM, Mobley WC, Rezaie P, Pearce DA, Cooper JD (2004) Late onset neurodegeneration in the Cln3−/− mouse model of juvenile neuronal ceroid lipofuscinosis is preceded by low level glial activation. Brain Res 1023:231–242PubMed

100.

Pontikis CC, Cotman SL, MacDonald ME, Cooper JD (2005) Thalamocortical neuron loss and localized astrocytosis in the Cln3Deltaex7/8 knock-in mouse model of Batten disease. Neurobiol Dis 20:823–836PubMed

101.

Radoja S, Frey AB, Vukmanovic S (2006) T-cell receptor signaling events triggering granule exocytosis. Crit Rev Immunol 26:265–290PubMed

102.

Ramirez-Montealegre D, Chattopadhyay S, Curran TM, Wasserfall C, Pritchard L, Schatz D, Petitto J, Hopkins D, She JX, Rothberg PG, Atkinson M, Pearce DA (2005) Autoimmunity to glutamic acid decarboxylase in the neurodegenerative disorder Batten disease. Neurology 64:743–745PubMed

103.

Ramirez-Montealegre D, Pearce DA (2005) Defective lysosomal arginine transport in juvenile Batten disease. Hum Mol Genet 14:3759–3773PubMed

104.

Ravetch JV, Bolland S (2001) IgG Fc receptors. Annu Rev Immunol 19:275–290PubMed

105.

Reuser AJ, Drost MR (2006) Lysosomal dysfunction, cellular pathology and clinical symptoms: basic principles. Acta Paediatr Suppl 95:77–82PubMed

106.

Riberdy JM, Avva RR, Geuze HJ, Cresswell P (1994) Transport and intracellular distribution of MHC class II molecules and associated invariant chain in normal and antigen-processing mutant cell lines. J Cell Biol 125:1225–1237PubMed

107.

Sagiv Y, Hudspeth K, Mattner J, Schrantz N, Stern RK, Zhou D, Savage PB, Teyton L, Bendelac A (2006) Cutting edge: impaired glycosphingolipid trafficking and NKT cell development in mice lacking Niemann-Pick type C1 protein. J Immunol 177:26–30PubMed

108.

Sandhoff K, Kolter T (2003) Biosynthesis and degradation of mammalian glycosphingolipids. Philos Trans R Soc Lond B Biol Sci 358:847–861PubMed

109.

Schmid D, Munz C (2005) Immune surveillance of intracellular pathogens via autophagy. Cell Death Differ 12(Suppl 2):1519–1527PubMed

110.

Schmid D, Dengjel J, Schoor O, Stevanovic S, Munz C (2006) Autophagy in innate and adaptive immunity against intracellular pathogens. J Mol Med 84:194–202PubMed

111.

Schofer O, Mischo B, Puschel W, Harzer K, Vanier MT (1998) Early-lethal pulmonary form of Niemann-Pick type C disease belonging to a second, rare genetic complementation group. Eur J Pediatr 157:45–49PubMed

112.

Schuchman EH, Miranda SR (1997) Niemann-Pick disease: mutation update, genotype/phenotype correlations, and prospects for genetic testing. Genet Test 1:13–19PubMed

113.

Scott C, Ioannou YA (2004) The NPC1 protein: structure implies function. Biochim Biophys Acta 1685:8–13PubMed

114.

Scriver CR (ed) (2001) The metabolic & molecular bases of inherited disease. McGraw-Hill, New York

115.

Seifert U, Maranon C, Shmueli A, Desoutter JF, Wesoloski L, Janek K, Henklein P, Diescher S, Andrieu M, de la Salle H, Weinschenk T, Schild H, Laderach D, Galy A, Haas G, Kloetzel PM, Reiss Y, Hosmalin A (2003) An essential role for tripeptidyl peptidase in the generation of an MHC class I epitope. Nat Immunol 4:375–379PubMed

116.

Sevin M, Lesca G, Baumann N, Millat G, Lyon-Caen O, Vanier MT, Sedel F (2007) The adult form of Niemann-Pick disease type C. Brain 130:120–133PubMed

117.

Sewell AC, Poets CF, Degen I, Stoss H, Pontz BF (1996) The spectrum of free neuraminic acid storage disease in childhood: clinical, morphological and biochemical observations in three non-Finnish patients. Am J Med Genet 63:203–208PubMed

118.

Shoenfeld Y, Gallant LA, Shaklai M, Livni E, Djaldetti M, Pinkhas J (1982) Gaucher’s disease: a disease with chronic stimulation of the immune system. Arch Pathol Lab Med 106:388–391PubMed

119.

Shoenfeld Y, Beresovski A, Zharhary D, Tomer Y, Swissa M, Sela E, Zimran A, Zevin S, Gilburd B, Blank M (1995) Natural autoantibodies in sera of patients with Gaucher’s disease. J Clin Immunol 15:363–372PubMed

120.

Sun H, Wolfe JH (2001) Recent progress in lysosomal alpha-mannosidase and its deficiency. Exp Mol Med 33:1–7PubMed

121.

Suzuki K (2003) Globoid cell leukodystrophy (Krabbe’s disease): update. J Child Neurol 18:595–603PubMed

122.

Tomatsu S, Gutierrez MA, Ishimaru T, Pena OM, Montano AM, Maeda H, Velez-Castrillon S, Nishioka T, Fachel AA, Cooper A, Thornley M, Wraith E, Barrera LA, Laybauer LS, Giugliani R, Schwartz IV, Frenking GS, Beck M, Kircher SG, Paschke E, Yamaguchi S, Ullrich K, Isogai K, Suzuki Y, Orii T, Noguchi A (2005) Heparan sulfate levels in mucopolysaccharidoses and mucolipidoses. J Inherit Metab Dis 28:743–757PubMed

123.

Tsuji D, Kuroki A, Ishibashi Y, Itakura T, Kuwahara J, Yamanaka S, Itoh K (2005) Specific induction of macrophage inflammatory protein 1-alpha in glial cells of Sandhoff disease model mice associated with accumulation of N-acetylhexosaminyl glycoconjugates. J Neurochem 92:1497–1507PubMed

124.

Tybulewicz VL, Tremblay ML, LaMarca ME, Willemsen R, Stubblefield BK, Winfield S, Zablocka B, Sidransky E, Martin BM, Huang SP, Mintzer KA, Westphal H, Mulligan RC, Ginns EI (1992) Animal model of Gaucher’s disease from targeted disruption of the mouse glucocerebrosidase gene. Nature 357:407–410PubMed

125.

Vervoort R, Gitzelmann R, Bosshard N, Maire I, Liebaers I, Lissens W (1998) Low beta-glucuronidase enzyme activity and mutations in the human beta-glucuronidase gene in mild mucopolysaccharidosis type VII, pseudodeficiency and a heterozygote. Hum Genet 102:69–78PubMed

126.

Virmani T, Gupta P, Liu X, Kavalali ET, Hofmann SL (2005) Progressively reduced synaptic vesicle pool size in cultured neurons derived from neuronal ceroid lipofuscinosis-1 knockout mice. Neurobiol Dis 20:314–323PubMed

127.

Vogler C, Birkenmeier EH, Sly WS, Levy B, Pegors C, Kyle JW, Beamer WG (1990) A murine model of mucopolysaccharidosis VII. Gross and microscopic findings in beta-glucuronidase-deficient mice. Am J Pathol 136:207–217PubMed

128.

Vogler C, Barker J, Sands MS, Levy B, Galvin N, Sly WS (2001) Murine mucopolysaccharidosis VIL: impact of therapies on the phenotype, clinical course, and pathology in a model of a lysosomal storage disease. Pediatr Dev Pathol 4:421–433PubMed

129.

Wada R, Tifft CJ, Proia RL (2000) Microglial activation precedes acute neurodegeneration in Sandhoff disease and is suppressed by bone marrow transplantation. Proc Natl Acad Sci USA 97:10954–10959PubMed

130.

Watts C (2001) Antigen processing in the endocytic compartment. Curr Opin Immunol 13:26–31PubMed

131.

Winau F, Schwierzeck V, Hurwitz R, Remmel N, Sieling PA, Modlin RL, Porcelli SA, Brinkmann V, Sugita M, Sandhoff K, Kaufmann SH, Schaible UE (2004) Saposin C is required for lipid presentation by human CD1b. Nat Immunol 5:169–174PubMed

132.

Wu YP, Matsuda J, Kubota A, Suzuki K (2000) Infiltration of hematogenous lineage cells into the demyelinating central nervous system of twitcher mice. J Neuropathol Exp Neurol 59:628–639PubMed

133.

Wu YP, McMahon EJ, Matsuda J, Suzuki K, Matsushima GK (2001) Expression of immune-related molecules is downregulated in twitcher mice following bone marrow transplantation. J Neuropathol Exp Neurol 60:1062–1074PubMed

134.

Wu YP, Proia RL (2004) Deletion of macrophage-inflammatory protein 1 alpha retards neurodegeneration in Sandhoff disease mice. Proc Natl Acad Sci USA 101:8425–8430PubMed

135.

Yamada Y, Kato K, Sukegawa K, Tomatsu S, Fukuda S, Emura S, Kojima S, Matsuyama T, Sly WS, Kondo N, Orii T (1998) Treatment of MPS VII (Sly disease) by allogeneic BMT in a female with homozygous A619V mutation. Bone Marrow Transplant 21:629–634PubMed

136.

Yamaguchi A, Katsuyama K, Nagahama K, Takai T, Aoki I, Yamanaka S (2004) Possible role of autoantibodies in the pathophysiology of GM2 gangliosidoses. J Clin Invest 113:200–208PubMed

137.

Yanagawa M, Tsukuba T, Nishioku T, Okamoto Y, Okamoto K, Takii R, Terada Y, Nakayama KI, Kadowaki T, Yamamoto K (2007) Cathepsin E deficiency induces a novel form of lysosomal storage disorder showing the accumulation of lysosomal membrane sialoglycoproteins and the elevation of lysosomal pH in macrophages. J Biol Chem 282:1851–1862PubMed

138.

Zhou D, Mattner J, Cantu C III, Schrantz N, Yin N, Gao Y, Sagiv Y, Hudspeth K, Wu YP, Yamashita T, Teneberg S, Wang D, Proia RL, Levery SB, Savage PB, Teyton L, Bendelac A (2004) Lysosomal glycosphingolipid recognition by NKT cells. Science 306:1786–1789PubMed

139.

Ziegler HK, Unanue ER (1982) Decrease in macrophage antigen catabolism caused by ammonia and chloroquine is associated with inhibition of antigen presentation to T cells. Proc Natl Acad Sci USA 79:175–178PubMed

140.

Zimran A, Abrahamov A, Aker M, Matzner Y (1993) Correction of neutrophil chemotaxis defect in patients with Gaucher disease by low-dose enzyme replacement therapy. Am J Hematol 43:69–71PubMed

Title: Immune system irregularities in lysosomal storage disorders
Authors: Julian A. Castaneda
Ming J. Lim
Jonathan D. Cooper
David A. Pearce
Publication date: 01-02-2008
Publisher: Springer-Verlag
Published in: Acta Neuropathologica / Issue 2/2008
Print ISSN: 0001-6322
Electronic ISSN: 1432-0533
DOI: https://doi.org/10.1007/s00401-007-0296-4

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Immune system irregularities in lysosomal storage disorders

Abstract

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 2/2008

Pitfalls in the assessment of MGMT expression and in its correlation with survival in diffuse astrocytomas: proposal of a feasible immunohistochemical approach

Acta Neuropathologica and their case reports

Tracing of temporo-entorhinal connections in the human brain: cognitively impaired argyrophilic grain disease cases show dendritic alterations but no axonal disconnection of temporo-entorhinal association neurons

A cell culture model for investigation of Hirano bodies

MGMT immunoexpression predicts responsiveness of pituitary tumors to temozolomide therapy

Shifting of parvalbumin expression in the rat retina in experimentally induced diabetes